Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Balance Sheets

v3.22.1
Unaudited Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Assets    
Cash and cash equivalents $ 16,455 $ 21,729
Restricted cash 6,963 7,213
Accounts receivable, net 9,716 6,792
Inventories, net 8,284 5,245
Prepaid expenses and other current assets 2,874 2,940
Total Current Assets 44,292 43,919
Fixed assets, net 490 369
Right-of-use assets, operating lease 44 56
Intangible assets, net 11,205 11,586
Goodwill 18,614 18,614
Other assets 101 116
Total Assets 74,746 74,660
Current Liabilities    
Accounts payable 5,726 4,553
Accrued and other liabilities 1,448 1,879
Term loan, net 979 855
Operating lease liability 46 54
Total Current Liabilities 8,199 7,341
Non-current Liabilities    
Term loan, net 4,237 4,559
Line of credit, net 7,360 4,856
Deferred tax liability 24 24
Operating lease liability 0 5
Total Non-current Liabilities 11,621 9,444
Total Liabilities 19,820 16,785
Stockholders’ Equity (Deficit)    
Common Stock, $0.001 par value, 200,000,000 shares authorized, 29,364,712 and 29,146,367 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 29 29
Series F Preferred Stock, $0.001 par value, 30,000 shares authorized, 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 0 0
Additional paid-in capital 318,193 317,102
Accumulated deficit (263,296) (259,256)
Total Stockholders’ Equity (Deficit) 54,926 57,875
Total Liabilities and Stockholders’ Equity (Deficit) $ 74,746 $ 74,660